Current issues in adjuvant treatment of stage II colon cancer. - Wikidata - awgldk - TriplyDB

Current issues in adjuvant treatment of stage II colon cancer.

Current issues in adjuvant treatment of stage II colon cancer.

http://www.wikidata.org/entity/Q36449275

about

Adjuvant Therapy for completely resected Stage II Colon Cancer GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study Novel translational strategies in colorectal cancer research.Stage II colorectal cancer: lack of prognostic model Over-expression of the ATP5J gene correlates with cell migration and 5-fluorouracil sensitivity in colorectal cancer.Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer.Establishment of new predictive markers for distant recurrence of colorectal cancer using lectin microarray analysis.Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial--the PRODIGE 22--ECKINOXE trial.Focus on 16p13.3 Locus in Colon Cancer Molecular staging individualizing cancer management.Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology Development and progression of colorectal neoplasia.GUCY2C molecular staging personalizes colorectal cancer patient management Inequity in colorectal cancer treatment and outcomes: a population-based study.Cost-effectiveness of adjuvant FOLFOX and 5FU/LV chemotherapy for patients with stage II colon cancer Cost of care for colorectal cancer in Ireland: a health care payer perspective.Recent approaches to identifying biomarkers for high-risk stage II colon cancer.Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.[Multimodality therapy of colorectal cancer].Genomic classifiers in colon cancer - clinical utility.Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability.Anastomotic leakage contributes to the risk for systemic recurrence in stage II colorectal cancer.Understanding racial differences in colorectal cancer aids in individualized medicine.Optimal use of adjuvant chemotherapy in stage II colorectal cancer.Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients.PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis.Methylation status in patients with early stage colon cancer: A new prognostic marker?

P2860

Q24242231-D6215A50-8B6B-4915-86FC-4AA6471622A6 Q24641833-B5FF5AA0-3F9F-4DF8-9EDA-E05B34BC54A8 Q28252178-F43B5BA7-A036-47D3-B6E2-EFB524458358 Q33564901-9B90B6A0-8D00-4C9C-B607-E6973F59CDB0 Q34382804-DF9CD904-E9E6-4FFA-99AA-BFB94CDADF53 Q34803848-D1E8199A-0C21-4555-9DB2-138681893498 Q35017086-EF645866-A9C6-4242-B81D-389E52AE8533 Q35071668-9689A656-410B-4561-8408-5ADDB73C25FA Q35084954-8A115C77-9F9B-42CA-9B08-A27A0B302F16 Q35686487-83CE0621-7D06-407C-A50E-7EFAF01583B4 Q35722912-E6DF86CB-A9EF-489F-AA7E-6EB57B794127 Q35854173-7D7D91A9-BCBC-418C-ADC4-27C2A5D8F808 Q36023435-D0BC335D-1C52-4ED3-905F-597361586669 Q36241935-F53A0E02-6C45-4420-B911-ABCE1E9C78F8 Q36336227-2ABADE9F-9C5B-490C-9B9F-94CDE8F1454A Q36785920-53F32F85-BD06-4DD0-996E-E48E85FECB15 Q37651586-194D9E7B-1548-4129-83F1-E3EB089B011C Q37884446-22ECD0D4-6297-49DE-B09D-FB578F8FC229 Q38041974-A0A17D6C-4500-4ACF-87AD-BBD3ACBF87B9 Q38162282-C7EC789E-DF16-4A6A-8371-EBB288C8967B Q42850467-F573F700-D60D-4299-9542-803594969401 Q43155725-D0F2DAD3-6280-4AED-8745-A638EA5A22D5 Q44785500-2FB0318B-BBD6-4EC3-B520-C5A0C2065B0A Q45025607-DE7433E1-4B9B-4327-ABE7-A491FED220D2 Q46196659-3C80C8BA-C814-4D66-80D1-9E26DF9C69C4 Q51046352-C5190D40-9046-4553-B976-4AA80EC67D6C Q53028836-A181F2D8-CC15-4037-B3D9-A49BF455E689 Q54500317-6302BDF5-C7BF-426C-ADA9-B63278B1FC24 Q54568696-DC6ED441-FA2C-422D-A695-70395E7DDF32 Q58813294-576AD17D-0904-4B16-AA69-5B937F7EAF88

P2860

Current issues in adjuvant treatment of stage II colon cancer.

http://www.wikidata.org/entity/Q36449275

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Current issues in adjuvant treatment of stage II colon cancer.

@ast

Current issues in adjuvant treatment of stage II colon cancer.

@en

type

label

Current issues in adjuvant treatment of stage II colon cancer.

@ast

Current issues in adjuvant treatment of stage II colon cancer.

@en

prefLabel

Current issues in adjuvant treatment of stage II colon cancer.

@ast

Current issues in adjuvant treatment of stage II colon cancer.

@en

P1433

Q36449275-15060FB6-B1CE-419A-B588-D4E9E3A2D19F

P1476

Q36449275-448F16F8-3EB1-416C-9022-EBBFF0651B4A

P2093

Q36449275-244A1505-8A8D-40E5-A879-107D8FB372BC

Q36449275-3FDC05D4-7DF0-433A-BD36-1015BE0D550C

Q36449275-53484CC9-0736-4DB9-84C3-A5E80ACFA1BA

Q36449275-54F17CAF-BB40-4FF8-A918-89C55E5B1528

Q36449275-70A0B635-F490-4DA7-B967-00C15A4BA5E5

Q36449275-F6FE9000-206C-426C-839F-10975E8EE540

P2888

Q36449275-080B1B89-EA08-45D6-926B-7887DC841C38

P304

Q36449275-E8BDA485-41C6-4128-8B20-80E55DEAD8BB

P31

Q36449275-DCFB0DD2-5A55-47BA-B0D1-267DDEFE47D3

P356

Q36449275-1F7EE1B2-B058-477B-817A-31281ECF5AF5

P433

Q36449275-884824A7-A1EE-4319-92CB-7DC67534484B

P478

Q36449275-DBCFF831-CE18-44B4-A80B-6D22458D7695

P50

Q36449275-A05FD157-B0D7-4610-939E-6FBB8B616E90

Q36449275-A20C8923-B046-42FB-8350-6D6259E711F1

Q36449275-B647DC24-F8ED-4758-9B56-0B77DB74D4FB

P577

Q36449275-7B1A03B3-203A-4D5C-A78B-A52FE4CF9F56

P6179

Q36449275-ACC39694-4717-421D-B7CD-77D69A184D1D

P698

Q36449275-E1F9E8FD-422D-4B4A-A21F-813D34AF93C3

P356

ASO.2006.07.003

P1433

Annals of Surgical Oncology

P1476

Current issues in adjuvant treatment of stage II colon cancer.

@en

P2093

Alberto Sobrero

http://www.w3.org/2001/XMLSchema#string

Corrado Boni

http://www.w3.org/2001/XMLSchema#string

Daniel Sargent

http://www.w3.org/2001/XMLSchema#string

Jean-Louis Misset

http://www.w3.org/2001/XMLSchema#string

Michael O'Connell

http://www.w3.org/2001/XMLSchema#string

Thierry André

http://www.w3.org/2001/XMLSchema#string

P2888

aso.2006.07.003

P304

887-898

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/ASO.2006.07.003

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Josep Tabernero

Aimery de Gramont

P577

2006-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1052672943

http://www.w3.org/2001/XMLSchema#string

P698

16614880

http://www.w3.org/2001/XMLSchema#string